| Murine GPRC6A mediates cellular responses to L-amino acids, but not osteocalcin variants P Rueda, E Harley, Y Lu, GD Stewart, S Fabb, N Diepenhorst, B Cremers, ... PloS one 11 (1), e0146846, 2016 | 49 | 2016 |
| Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1) NA Diepenhorst, EJ Petrie, CZ Chen, A Wang, MA Hossain, ... Journal of Biological Chemistry 289 (50), 34938-34952, 2014 | 39 | 2014 |
| Divergent effects of strontium and calcium‐sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity NA Diepenhorst, K Leach, AN Keller, P Rueda, AE Cook, TL Pierce, ... British journal of pharmacology 175 (21), 4095-4108, 2018 | 34 | 2018 |
| Mannoury la Cour DM Riddy, AE Cook, DM Shackleford, TL Pierce, E Mocaer C., Mocaer, E., Summers, RJ, Charman, WN, Sexton, PM, Christopoulos, A …, 2016 | 29* | 2016 |
| Isoform-specific biased agonism of histamine H3 receptor agonists DM Riddy, AE Cook, NA Diepenhorst, S Bosnyak, R Brady, CM La Cour, ... Molecular pharmacology 91 (2), 87-99, 2017 | 23 | 2017 |
| G protein-coupled receptors as anabolic drug targets in osteoporosis N Diepenhorst, P Rueda, AE Cook, P Pastoureau, M Sabatini, ... Pharmacology & therapeutics 184, 1-12, 2018 | 18 | 2018 |
| High throughput, quantitative analysis of human osteoclast differentiation and activity NA Diepenhorst, CJ Nowell, P Rueda, K Henriksen, T Pierce, AE Cook, ... Analytical biochemistry 519, 51-56, 2017 | 12 | 2017 |
| Development of a scaffold displaying exoloops of RXFP1 NA Diepenhorst, PR Gooley, MJ Stone, RA Bathgate Ital. J. Anat. Embryol 118 (1 Suppl), 1, 2013 | 6 | 2013 |
| Mannoury la Cour C., Mocaer E., Summers RJ, Charman WN, Sexton PM, Christopoulos A., Langmead CJ, 2016. Isoform-specific biased agonism of histamine H3 receptor agonists DM Riddy, AE Cook, NA Diepenhorst, S Bosnyak, R Brady Mol Pharmacol 91 (2), 87-99, 0 | 6 | |
| Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms DM Riddy, HL Kammoun, AJ Murphy, S Bosnyak-Gladovic, ... BMJ Open Diabetes Research and Care 9 (2), e002285, 2021 | 5 | 2021 |
| Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders M Ubhayarathna, CJ Langmead, NA Diepenhorst, GD Stewart British Journal of Pharmacology, 2023 | 2 | 2023 |
| Intratumoral presence of the genotoxic gut bacteria pks+E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with … JE Joo, YL Chu, P Georgeson, R Walker, K Mahmood, M Clendenning, ... British Journal of Cancer, 1-13, 2024 | | 2024 |
| Molecular and structural insights into the serotonin 5-HT2C receptor as a therapeutic target for substance use disorders M Ubhayarathna, C Langmead, N Diepenhorst, G Stewart | | 2022 |
| Isoform-Specific Biased Agonism of Histamine H-3 Receptor Agonists (vol 91, pg 87, 2017) DM Riddy, AE Cook, NA Diepenhorst, S Bosnyak, R Brady, MC la Cour, ... MOLECULAR PHARMACOLOGY 91 (3), 263-263, 2017 | | 2017 |
| Isoform-specific bias of histamine H3 receptor agonists D Riddy, AE Cook, N Diepenhorst, S Bosnyak, R Brady, CM La Cour, ... ASCEPT-MPGPCR Joint Scientific Meeting 2016: Therapeutic targeting: right …, 2016 | | 2016 |
| Use of hemi-equilibrium to determine the dissociation kinetics of histamine H3 receptor antagonists. S Bosnyak, D Riddy, AE Cook, N Diepenhorst, PM Sexton, ... ASCEPT-MPGPCR 2014, 2014 | | 2014 |
| A Novel Approach for Investigating GPCR/ligand Interactions: Analysis of the Secondary Binding Site Within RXFP1 N Diepenhorst University of Melbourne, Department of Biochemistry and Molecular Biology, 2013 | | 2013 |
